<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0083">
 <label>83</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Eldehna</surname>
    <given-names>WM</given-names>
   </name>, 
   <name name-style="western">
    <surname>El Kerdawy</surname>
    <given-names>AM</given-names>
   </name>, 
   <name name-style="western">
    <surname>Al-Ansary</surname>
    <given-names>GH</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Type IIA - Type IIB protein tyrosine kinase inhibitors hybridization as an efficient approach for potent multikinase inhibitor development: design, synthesis, anti-proliferative activity, multikinase inhibitory activity and molecular modeling of novel indolinone-based ureides and amides</article-title>. 
  <source>Eur J Med Chem</source>
  <year>2019</year>;
  <volume>163</volume>:
  <fpage>37</fpage>–
  <lpage>53</lpage>.
  <pub-id pub-id-type="pmid">30503942</pub-id>
 </mixed-citation>
</ref>
